Franklin R. Toapanta, Ph.D.
Affiliations: | 2006 | University of Pittsburgh, Pittsburgh, PA, United States |
Area:
Immunology, Microbiology BiologyGoogle:
"Franklin Toapanta"Parents
Sign in to add mentor| Ted M. Ross | grad student | 2006 | University of Pittsburgh | |
| (Immune enhancement mechanisms by the complement protein C3d.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Toapanta FR, Hu J, Meron-Sudai S, et al. (2023) Further characterization of -specific (memory) B cells induced in healthy volunteer recipients of SF2a-TT15, a 2a synthetic glycan-based vaccine candidate. Frontiers in Immunology. 14: 1291664 |
| Allen JC, Toapanta FR, Baliban SM, et al. (2023) Reduced immunogenicity of a live serovar Typhimurium vaccine in aged mice. Frontiers in Immunology. 14: 1190339 |
| Hernandez AM, Mossman JA, Toapanta FR, et al. (2022) Altered transcriptional responses in the lungs of aged mice after influenza infection. Immunity & Ageing : I & A. 19: 27 |
| Higginson EE, Panda A, Toapanta FR, et al. (2021) Immunogenicity and efficacy of live-attenuated murium vaccine candidate CVD 1926 in a rhesus macaque model of gastroenteritis. Infection and Immunity. IAI0008721 |
| Allen JC, Toapanta FR, Chen W, et al. (2020) Understanding immunosenescence and its impact on vaccination of older adults. Vaccine |
| Edelman R, Deming ME, Toapanta FR, et al. (2020) The SENIEUR protocol and the efficacy of hepatitis B vaccination in healthy elderly persons by age, gender, and vaccine route. Immunity & Ageing : I & A. 17: 9 |
| Mani S, Toapanta FR, McArthur MA, et al. (2019) Role of antigen specific T and B cells in systemic and mucosal immune responses in ETEC and Shigella infections, and their potential to serve as correlates of protection in vaccine development. Vaccine |
| Hegerle N, Choi M, Sinclair J, et al. (2018) Development of a broad spectrum glycoconjugate vaccine to prevent wound and disseminated infections with Klebsiella pneumoniae and Pseudomonas aeruginosa. Plos One. 13: e0203143 |
| Davis CL, Wahid R, Toapanta FR, et al. (2018) Correction: A clinically parameterized mathematical model of Shigella immunity to inform vaccine design. Plos One. 13: e0196367 |
| Toapanta FR, Bernal PJ, Kotloff KL, et al. (2018) T cell mediated immunity induced by the live-attenuated Shigella flexneri 2a vaccine candidate CVD 1208S in humans. Journal of Translational Medicine. 16: 61 |